- Activity pressure is positive on the latest completed week.
002390
KSC
Week ended 07 Aug 2026
Weekly Investor Report
HANDOK Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
9,500 KRW
6.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 48.8% of its 52-week range. The latest completed week returned 6.0%, after a 20.4% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
32
out of 100
Latest Close
9,500 KRW
7 Aug 2026
1W Return
6.0%
latest completed week
4W Return
20.4%
short-term follow-through
12W Return
-1.8%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 44.75% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.0%
Latest completed week; four-week move 20.4%.
Indicator stack
11/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.75%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 48.8% of its 52-week range. The latest completed week returned 6.0%, after a 20.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1012-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 20.4% over four weeks, -1.8% over 12 weeks, and -19.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.14Latest activity-pressure read.
Pressure change109.1%Four-week change in activity pressure.
Leadership-30.87Latest relative-leadership reading.
RS change44.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.1%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+10.6%Week of 3 Jul.
Worst week-12.6%Week of 26 Jun.
Latest week+6.0%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks0
Modest losses11
Sharp losses4
Recent vol6.5%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split20/31Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorKR Healthcare
4-week rank3 / 63
Group average4.4%
Trend breadth1.6%
Trend1.6%active weekly trend signals
MD9.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryKR Drug Manufacturers - Specialty & Generic
4-week rank2 / 44
Group average4.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD4.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 44.75%Next-week expectancy is negative with a 44.75% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Handok, Inc. Revenue Breakdown – KRX:002390 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 9,500 KRW | 6.0% | 9,686 KRW | 11,953 KRW | 0.14 | -30.87 | 55.3K | Off |
| 31 Jul 2026 | 8,960 KRW | 3.1% | 9,734 KRW | 11,977 KRW | -0.26 | -39.27 | 95.7K | Off |
| 24 Jul 2026 | 8,690 KRW | 3.5% | 9,804 KRW | 12,001 KRW | -0.72 | -43.06 | 81.5K | Off |
| 17 Jul 2026 | 8,400 KRW | 6.5% | 9,884 KRW | 12,024 KRW | -1.13 | -47.09 | 259.1K | Off |
| 10 Jul 2026 | 7,890 KRW | 6.5% | 9,976 KRW | 12,053 KRW | -1.56 | -55.58 | 67.5K | Off |
| 3 Jul 2026 | 7,410 KRW | 10.6% | 10,089 KRW | 12,087 KRW | -1.76 | -62.24 | 31.2K | Off |
| 26 Jun 2026 | 6,700 KRW | -12.6% | 10,231 KRW | 12,123 KRW | -1.82 | -67.90 | 30.6K | Off |
| 19 Jun 2026 | 7,670 KRW | -2.7% | 10,397 KRW | 12,167 KRW | -1.73 | -66.60 | 20.2K | Off |
| 12 Jun 2026 | 7,880 KRW | -3.1% | 10,525 KRW | 12,205 KRW | -1.68 | -62.59 | 11.1K | Off |
| 5 Jun 2026 | 8,130 KRW | -3.3% | 10,649 KRW | 12,242 KRW | -1.59 | -62.41 | 21.1K | Off |
| 29 May 2026 | 8,410 KRW | -8.7% | 10,752 KRW | 12,283 KRW | -1.49 | -63.38 | 332.9K | Off |
| 22 May 2026 | 9,210 KRW | -4.8% | 10,845 KRW | 12,322 KRW | -1.38 | -57.65 | 124.0K | Off |
| 15 May 2026 | 9,670 KRW | -2.8% | 10,916 KRW | 12,355 KRW | -1.07 | -54.44 | 180.7K | Off |
| 8 May 2026 | 9,950 KRW | -3.5% | 10,975 KRW | 12,384 KRW | -0.66 | -54.07 | 177.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.